Compugen (CGEN) Research & Development (2009 - 2026)
Compugen (CGEN) reported Research & Development of $6.9 million for Q1 2026, up 20.16% on a YoY basis from $5.8 million in Q1 2025, and up 25.15% sequentially from $5.5 million in Q4 2025.
Compugen (CGEN) Research & Development (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Research & Development data on file, last reported at $6.9 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 20.16% year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $23.9 million (down 1.04% YoY), and the FY2025 full-year result was $22.8 million, down 8.27% from the prior year.
- Research & Development advanced to $6.9 million in Q1 2026, from $5.5 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $10.9 million in Q4 2023 to a low of $5.5 million in Q4 2025.
- A 5-year average of $7.0 million and a median of $6.8 million in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development jumped 49.15% in 2023 and sank 45.91% in 2024, its largest moves.
- Tracing CGEN's Research & Development over 5 years: stood at $7.3 million in 2022, then jumped by 49.15% to $10.9 million in 2023, then slumped by 45.91% to $5.9 million in 2024, then retreated by 6.23% to $5.5 million in 2025, then climbed by 25.15% to $6.9 million in 2026.
- Business Quant data shows CGEN's Research & Development at $6.9 million in Q1 2026, $5.5 million in Q4 2025, and $5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.94 Mn |
| Dec 31, 2025 | 5.54 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Jun 30, 2025 | 5.64 Mn |
| Mar 31, 2025 | 5.77 Mn |
| Dec 31, 2024 | 5.91 Mn |
| Sep 30, 2024 | 6.31 Mn |
| Jun 30, 2024 | 6.18 Mn |
| Mar 31, 2024 | 6.41 Mn |
| Dec 31, 2023 | 10.93 Mn |
| Sep 30, 2023 | 8.34 Mn |
| Jun 30, 2023 | 7.76 Mn |
| Mar 31, 2023 | 7.45 Mn |
| Dec 31, 2022 | 7.33 Mn |
| Sep 30, 2022 | 9.34 Mn |
| Jun 30, 2022 | 6.81 Mn |
| Mar 31, 2022 | 7.17 Mn |
| Dec 31, 2021 | 5.84 Mn |
| Sep 30, 2021 | 8.73 Mn |
| Jun 30, 2021 | 6.80 Mn |